Home-Based Exercise Program for Fibromyalgia
FIBRO-EX
Effects of Home-based Exercise Program on Pain, Fatigue, Quality of Life, Depression, and Exercise Perception in Fibromyalgia Patients: A Randomized Controlled Trial
2 other identifiers
interventional
60
1 country
1
Brief Summary
This study aims to evaluate the effects of a home-based exercise program on patients with fibromyalgia. Participants will be randomly assigned to either an exercise group or a control group. The study will last 12 weeks, and the outcomes will measure improvements in pain, physical function, and quality of life. Participation involves attending scheduled assessments at the Department of Physical Medicine and Rehabilitation, University Hospital. This study helps understand whether a structured home exercise program can benefit individuals with fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
September 12, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedOctober 3, 2025
September 1, 2025
1 year
September 12, 2025
September 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain intensity (Visual Analog Scale, VAS)
Change in pain intensity from baseline to week 12 measured by the Visual Analog Scale (VAS).The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain. Higher scores indicate worse pain.
12 weeks
Secondary Outcomes (4)
Change in quality of life (Fibromyalgia Impact Questionnaire, FIQ)
12 weeks
Change in fatigue severity (Visual Analog Scale, VAS)
12 weeks
Change in depressive symptoms (Beck Depression Inventory, BDI)
12 weeks
Change in exercise perception (Exercise Benefits and Barriers Scale, EBBS)
12 weeks
Study Arms (2)
Home-based Exercise
OTHERParticipants receive usual care without any additional structured exercise program. Assessments are performed at baseline and after 12 weeks.
Control
NO INTERVENTIONParticipants receive usual care without any additional structured exercise program. Assessments are performed at baseline and after 12 weeks.
Interventions
Participants follow a 12-week home-based exercise program including aerobic, strengthening, and flexibility exercises. Assessments are done at baseline and after 12 weeks.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- Voluntary participation in the study
- Diagnosis of fibromyalgia according to the 2016 ACR criteria
- Female gender
- Pain severity score of ≥4/10 on the Visual Analog Scale (VAS)
You may not qualify if:
- Pregnancy
- History of malignancy
- Pre-existing neurological, endocrine, infectious, or inflammatory rheumatic diseases
- Severe psychiatric disorders
- Advanced cardiac, respiratory, or musculoskeletal conditions that would prevent exercise
- Participation in an exercise or physical therapy program within the last 6 months
- Any changes to current medical treatment during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kütahya Health Sciences University Hospital
Kütahya, Kütahya, 43290, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nazlı Karaman, MD
Kütahya Health Sciences University, Department of Physical Medicine and Rehabilitation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No parties were masked in this study
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2025
First Posted
October 3, 2025
Study Start
June 20, 2021
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
October 3, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy and confidentiality concerns of study participants.